NCT03518034: A reported trial by AbbVie
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03518034 |
|---|---|
| Title | Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 3, 2018 |
| Completion date | Jan. 19, 2023 |
| Required reporting date | Jan. 19, 2024, midnight |
| Actual reporting date | Jan. 5, 2024 |
| Date last checked at ClinicalTrials.gov | April 8, 2025 |
| Days late | None |